Making the case for UK medicines manufacturing

2 March 2016 The Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE

Being organised by ABPI and the MHRA, this is a must-attend event for senior leaders and decision makers with strategic responsibility for securing, developing and future-proofing manufacturing networks in the pharmaceutical industry.

Securing investment, reviewing locations and scanning new technologies are just part of the equation: recruiting a skilled workforce, gaining clarity on fiscal policies and complying with regulation can add additional complexity.

“Making the case for UK medicines manufacturing” explores the drivers of positive relationships that will support future commercial success for our sector and illustrate, through evidence-based examples, the benefit of the manufacturing ecosystem in the UK.

For more information, follow the link here to the event website.